Cetuximab Concomitant with Second-Line Radiation Therapy in Patients with Locally Advanced Recurrent Squamous Cell Head and Neck Cancer
oleh: Muge Akmansu, Suleyman Buyukberber, Sevilay Iren, Umut Demirci, Gul Kanyilmaz, Ugur Coskun, Huseyin Bora
| Format: | Article |
|---|---|
| Diterbitkan: | Karger Publishers 2010-12-01 |
Deskripsi
We presented 9 recurrent head and neck carcinoma patients. Priorly all of them had received radiochemotherapy. We used cetuximab and irradiation concomitantly. Overall survival analysis of the patients was performed using the Kaplan-Meier method on SPSS version 15.0. Based on this calculation, mean follow-up duration is 12.8 months. Mean survival time is 19.8 months and annual mean survival rate is 59.3%.